Global Infectious Disease Biomarker Testing Market Research Report 2025(Status and Outlook)
Description
Report Overview
Infectious disease biomarker testing involves the identification and measurement of specific biological markers—such as proteins, nucleic acids, or metabolites—that indicate the presence, progression, or severity of an infection caused by pathogens like bacteria, viruses, fungi, or parasites. These biomarkers enable early and accurate diagnosis, monitoring of disease progression, and assessment of treatment efficacy, playing a critical role in personalized medicine and public health. The market encompasses a wide range of technologies, including immunoassays, molecular diagnostics (PCR, NGS), and point-of-care testing, driven by the increasing prevalence of infectious diseases, growing antimicrobial resistance, and advancements in diagnostic technologies. Key applications include respiratory infections (e.g., COVID-19, influenza), sexually transmitted infections (e.g., HIV, HPV), and tropical diseases (e.g., malaria, dengue), with demand further fueled by globalization, rising healthcare expenditure, and the need for rapid, decentralized testing solutions. Major players include diagnostic companies, biotechnology firms, and academic research institutions, with innovation focused on multiplex assays, AI-driven diagnostics, and portable testing devices. Regulatory approvals, reimbursement policies, and emerging outbreaks significantly influence market dynamics, while challenges like high development costs and limited access in low-resource settings persist. The market is projected to grow steadily, supported by ongoing pandemic preparedness efforts and the integration of biomarker testing into routine clinical practice.
The global Infectious Disease Biomarker Testing market size was estimated at USD 1500.19 million in 2024, exhibiting a CAGR of 8.20% during the forecast period.
This report provides a deep insight into the global Infectious Disease Biomarker Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Disease Biomarker Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Disease Biomarker Testing market in any manner.
Global Infectious Disease Biomarker Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
Market Segmentation (by Type)
PCR
NGS
ELISA or EIA
IHC
ISH
Others
Market Segmentation (by Application)
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Infectious Disease Biomarker Testing Market
Overview of the regional outlook of the Infectious Disease Biomarker Testing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Biomarker Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Biomarker Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Infectious disease biomarker testing involves the identification and measurement of specific biological markers—such as proteins, nucleic acids, or metabolites—that indicate the presence, progression, or severity of an infection caused by pathogens like bacteria, viruses, fungi, or parasites. These biomarkers enable early and accurate diagnosis, monitoring of disease progression, and assessment of treatment efficacy, playing a critical role in personalized medicine and public health. The market encompasses a wide range of technologies, including immunoassays, molecular diagnostics (PCR, NGS), and point-of-care testing, driven by the increasing prevalence of infectious diseases, growing antimicrobial resistance, and advancements in diagnostic technologies. Key applications include respiratory infections (e.g., COVID-19, influenza), sexually transmitted infections (e.g., HIV, HPV), and tropical diseases (e.g., malaria, dengue), with demand further fueled by globalization, rising healthcare expenditure, and the need for rapid, decentralized testing solutions. Major players include diagnostic companies, biotechnology firms, and academic research institutions, with innovation focused on multiplex assays, AI-driven diagnostics, and portable testing devices. Regulatory approvals, reimbursement policies, and emerging outbreaks significantly influence market dynamics, while challenges like high development costs and limited access in low-resource settings persist. The market is projected to grow steadily, supported by ongoing pandemic preparedness efforts and the integration of biomarker testing into routine clinical practice.
The global Infectious Disease Biomarker Testing market size was estimated at USD 1500.19 million in 2024, exhibiting a CAGR of 8.20% during the forecast period.
This report provides a deep insight into the global Infectious Disease Biomarker Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Disease Biomarker Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Disease Biomarker Testing market in any manner.
Global Infectious Disease Biomarker Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
Market Segmentation (by Type)
PCR
NGS
ELISA or EIA
IHC
ISH
Others
Market Segmentation (by Application)
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Infectious Disease Biomarker Testing Market
Overview of the regional outlook of the Infectious Disease Biomarker Testing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Biomarker Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Biomarker Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
164 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Infectious Disease Biomarker Testing
- 1.2 Key Market Segments
- 1.2.1 Infectious Disease Biomarker Testing Segment by Type
- 1.2.2 Infectious Disease Biomarker Testing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Infectious Disease Biomarker Testing Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Infectious Disease Biomarker Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Infectious Disease Biomarker Testing Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Infectious Disease Biomarker Testing Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Infectious Disease Biomarker Testing Product Life Cycle
- 3.3 Global Infectious Disease Biomarker Testing Sales by Manufacturers (2020-2025)
- 3.4 Global Infectious Disease Biomarker Testing Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Infectious Disease Biomarker Testing Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Infectious Disease Biomarker Testing Market Competitive Situation and Trends
- 3.8.1 Infectious Disease Biomarker Testing Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Infectious Disease Biomarker Testing Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Infectious Disease Biomarker Testing Industry Chain Analysis
- 4.1 Infectious Disease Biomarker Testing Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Infectious Disease Biomarker Testing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Infectious Disease Biomarker Testing Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease Biomarker Testing Market
- 5.7 ESG Ratings of Leading Companies
- 6 Infectious Disease Biomarker Testing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Infectious Disease Biomarker Testing Sales Market Share by Type (2020-2025)
- 6.3 Global Infectious Disease Biomarker Testing Market Size Market Share by Type (2020-2025)
- 6.4 Global Infectious Disease Biomarker Testing Price by Type (2020-2025)
- 7 Infectious Disease Biomarker Testing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Infectious Disease Biomarker Testing Market Sales by Application (2020-2025)
- 7.3 Global Infectious Disease Biomarker Testing Market Size (M USD) by Application (2020-2025)
- 7.4 Global Infectious Disease Biomarker Testing Sales Growth Rate by Application (2020-2025)
- 8 Infectious Disease Biomarker Testing Market Sales by Region
- 8.1 Global Infectious Disease Biomarker Testing Sales by Region
- 8.1.1 Global Infectious Disease Biomarker Testing Sales by Region
- 8.1.2 Global Infectious Disease Biomarker Testing Sales Market Share by Region
- 8.2 Global Infectious Disease Biomarker Testing Market Size by Region
- 8.2.1 Global Infectious Disease Biomarker Testing Market Size by Region
- 8.2.2 Global Infectious Disease Biomarker Testing Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Infectious Disease Biomarker Testing Sales by Country
- 8.3.2 North America Infectious Disease Biomarker Testing Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Infectious Disease Biomarker Testing Sales by Country
- 8.4.2 Europe Infectious Disease Biomarker Testing Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Infectious Disease Biomarker Testing Sales by Region
- 8.5.2 Asia Pacific Infectious Disease Biomarker Testing Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Infectious Disease Biomarker Testing Sales by Country
- 8.6.2 South America Infectious Disease Biomarker Testing Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Infectious Disease Biomarker Testing Sales by Region
- 8.7.2 Middle East and Africa Infectious Disease Biomarker Testing Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Infectious Disease Biomarker Testing Market Production by Region
- 9.1 Global Production of Infectious Disease Biomarker Testing by Region(2020-2025)
- 9.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Region (2020-2025)
- 9.3 Global Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Infectious Disease Biomarker Testing Production
- 9.4.1 North America Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
- 9.4.2 North America Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Infectious Disease Biomarker Testing Production
- 9.5.1 Europe Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
- 9.5.2 Europe Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Infectious Disease Biomarker Testing Production (2020-2025)
- 9.6.1 Japan Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
- 9.6.2 Japan Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Infectious Disease Biomarker Testing Production (2020-2025)
- 9.7.1 China Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
- 9.7.2 China Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Abacus Diagnostica
- 10.1.1 Abacus Diagnostica Basic Information
- 10.1.2 Abacus Diagnostica Infectious Disease Biomarker Testing Product Overview
- 10.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Product Market Performance
- 10.1.4 Abacus Diagnostica Business Overview
- 10.1.5 Abacus Diagnostica SWOT Analysis
- 10.1.6 Abacus Diagnostica Recent Developments
- 10.2 ALPCO
- 10.2.1 ALPCO Basic Information
- 10.2.2 ALPCO Infectious Disease Biomarker Testing Product Overview
- 10.2.3 ALPCO Infectious Disease Biomarker Testing Product Market Performance
- 10.2.4 ALPCO Business Overview
- 10.2.5 ALPCO SWOT Analysis
- 10.2.6 ALPCO Recent Developments
- 10.3 Abbott Laboratories
- 10.3.1 Abbott Laboratories Basic Information
- 10.3.2 Abbott Laboratories Infectious Disease Biomarker Testing Product Overview
- 10.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Product Market Performance
- 10.3.4 Abbott Laboratories Business Overview
- 10.3.5 Abbott Laboratories SWOT Analysis
- 10.3.6 Abbott Laboratories Recent Developments
- 10.4 Agilent Technologies
- 10.4.1 Agilent Technologies Basic Information
- 10.4.2 Agilent Technologies Infectious Disease Biomarker Testing Product Overview
- 10.4.3 Agilent Technologies Infectious Disease Biomarker Testing Product Market Performance
- 10.4.4 Agilent Technologies Business Overview
- 10.4.5 Agilent Technologies Recent Developments
- 10.5 Becton
- 10.5.1 Becton Basic Information
- 10.5.2 Becton Infectious Disease Biomarker Testing Product Overview
- 10.5.3 Becton Infectious Disease Biomarker Testing Product Market Performance
- 10.5.4 Becton Business Overview
- 10.5.5 Becton Recent Developments
- 10.6 Dickinson and Company
- 10.6.1 Dickinson and Company Basic Information
- 10.6.2 Dickinson and Company Infectious Disease Biomarker Testing Product Overview
- 10.6.3 Dickinson and Company Infectious Disease Biomarker Testing Product Market Performance
- 10.6.4 Dickinson and Company Business Overview
- 10.6.5 Dickinson and Company Recent Developments
- 10.7 bioMérieux SA
- 10.7.1 bioMérieux SA Basic Information
- 10.7.2 bioMérieux SA Infectious Disease Biomarker Testing Product Overview
- 10.7.3 bioMérieux SA Infectious Disease Biomarker Testing Product Market Performance
- 10.7.4 bioMérieux SA Business Overview
- 10.7.5 bioMérieux SA Recent Developments
- 10.8 Bio-Rad Laboratories
- 10.8.1 Bio-Rad Laboratories Basic Information
- 10.8.2 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Overview
- 10.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Market Performance
- 10.8.4 Bio-Rad Laboratories Business Overview
- 10.8.5 Bio-Rad Laboratories Recent Developments
- 10.9 Danaher
- 10.9.1 Danaher Basic Information
- 10.9.2 Danaher Infectious Disease Biomarker Testing Product Overview
- 10.9.3 Danaher Infectious Disease Biomarker Testing Product Market Performance
- 10.9.4 Danaher Business Overview
- 10.9.5 Danaher Recent Developments
- 10.10 F. Hoffmann-La Roche
- 10.10.1 F. Hoffmann-La Roche Basic Information
- 10.10.2 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Overview
- 10.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Market Performance
- 10.10.4 F. Hoffmann-La Roche Business Overview
- 10.10.5 F. Hoffmann-La Roche Recent Developments
- 10.11 Hologic
- 10.11.1 Hologic Basic Information
- 10.11.2 Hologic Infectious Disease Biomarker Testing Product Overview
- 10.11.3 Hologic Infectious Disease Biomarker Testing Product Market Performance
- 10.11.4 Hologic Business Overview
- 10.11.5 Hologic Recent Developments
- 10.12 PerkinElmer
- 10.12.1 PerkinElmer Basic Information
- 10.12.2 PerkinElmer Infectious Disease Biomarker Testing Product Overview
- 10.12.3 PerkinElmer Infectious Disease Biomarker Testing Product Market Performance
- 10.12.4 PerkinElmer Business Overview
- 10.12.5 PerkinElmer Recent Developments
- 10.13 Qiagen
- 10.13.1 Qiagen Basic Information
- 10.13.2 Qiagen Infectious Disease Biomarker Testing Product Overview
- 10.13.3 Qiagen Infectious Disease Biomarker Testing Product Market Performance
- 10.13.4 Qiagen Business Overview
- 10.13.5 Qiagen Recent Developments
- 10.14 Quest Diagnostics Incorporated
- 10.14.1 Quest Diagnostics Incorporated Basic Information
- 10.14.2 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Overview
- 10.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Market Performance
- 10.14.4 Quest Diagnostics Incorporated Business Overview
- 10.14.5 Quest Diagnostics Incorporated Recent Developments
- 10.15 Siemens Healthineers
- 10.15.1 Siemens Healthineers Basic Information
- 10.15.2 Siemens Healthineers Infectious Disease Biomarker Testing Product Overview
- 10.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Product Market Performance
- 10.15.4 Siemens Healthineers Business Overview
- 10.15.5 Siemens Healthineers Recent Developments
- 10.16 Thermo Fisher Scientific
- 10.16.1 Thermo Fisher Scientific Basic Information
- 10.16.2 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Overview
- 10.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Market Performance
- 10.16.4 Thermo Fisher Scientific Business Overview
- 10.16.5 Thermo Fisher Scientific Recent Developments
- 11 Infectious Disease Biomarker Testing Market Forecast by Region
- 11.1 Global Infectious Disease Biomarker Testing Market Size Forecast
- 11.2 Global Infectious Disease Biomarker Testing Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Infectious Disease Biomarker Testing Market Size Forecast by Country
- 11.2.3 Asia Pacific Infectious Disease Biomarker Testing Market Size Forecast by Region
- 11.2.4 South America Infectious Disease Biomarker Testing Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease Biomarker Testing by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Infectious Disease Biomarker Testing Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Infectious Disease Biomarker Testing by Type (2026-2033)
- 12.1.2 Global Infectious Disease Biomarker Testing Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Infectious Disease Biomarker Testing by Type (2026-2033)
- 12.2 Global Infectious Disease Biomarker Testing Market Forecast by Application (2026-2033)
- 12.2.1 Global Infectious Disease Biomarker Testing Sales (K Units) Forecast by Application
- 12.2.2 Global Infectious Disease Biomarker Testing Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
